相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。World Health Organization-defined classification of myeloproliferative neoplasms: Morphological reproducibility and clinical correlations-The Danish experience
Ann Brinch Madelung et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up
Elisabeth Ejerblad et al.
HEMATOLOGY (2013)
Interobserver variability and the effect of education in the histopathological diagnosis of differentiated vulvar intraepithelial neoplasia
Loes C. G. van den Einden et al.
MODERN PATHOLOGY (2013)
Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemia
T. Barbui et al.
LEUKEMIA (2013)
The Role of Pathology Experts in Defining Practice Gaps in Continuing Pathology Education: What Do We Need to Know and How Can We Find Them?
Sarah Calkins et al.
ADVANCES IN ANATOMIC PATHOLOGY (2012)
Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls
Srdan Verstovsek et al.
BLOOD (2012)
European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis
Thomas Buhr et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis
Umberto Gianelli et al.
MODERN PATHOLOGY (2012)
A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
Srdan Verstovsek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Claire Harrison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification
Juergen Thiele et al.
BLOOD (2011)
The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera
Khadija Abdulkarim et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
Tiziano Barbui et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Danish Pathology Register
Beth Bjerregaard et al.
SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)
Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis
Maud Brousseau et al.
HISTOPATHOLOGY (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal
Jerry L. Spivak et al.
BLOOD (2008)
Prognostic implications of the European consensus for grading of bone marrow fibrosis in chronic idiopathic myelofibrosis
Claudia Vener et al.
BLOOD (2008)
Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes
Bridget S. Wilkins et al.
BLOOD (2008)
The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera
Hans Michael Kvasnicka et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2006)
Grade of bone marrow fibrosis is associated with relevant hematological findings - a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis
J Thiele et al.
ANNALS OF HEMATOLOGY (2006)
Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: A follow-up study on 309 patients
J Thiele et al.
LEUKEMIA & LYMPHOMA (2003)
分享论文
